Premier Biotech FaStep® AZ COVID-19P Rapid Test Device - 20/Box
Rapid Test Device
The Assure COVID-19 IgG/IgM rapid test device is a rapid lateral flow chromatographic immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, plasma (sodium EDTA) and fingerstick whole blood. The Assure COVID-19 IgG/IgM rapid test device is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The Assure COVID-19 IgG/IgM rapid test device should not be used to diagnose acute SARS-CoV-2 infection.
- Identify SARS-CoV-2 IgG – IgG is produced in later stages of the infection and can indicate recent or prior infection
- Identify SARS-CoV-2 IgM – IgM is an acute phase marker and is the first antibody produced by the immune system in response to an infection
- Differentiate – Monitor seroconversion and immunological status of patients by providing IgG and IgM specific results